LRRC41: A Nucleotide-Binding Protein with Multiple Functions (G10489)

Target Name: LRRC41

NCBI ID: G10489

LRRC41

LRRC41: A Nucleotide-Binding Protein with Multiple Functions

LRRC41 (MUF1) protein is a nucleotide-binding protein that plays a critical role in various cellular processes. It is a member of the leucine rich repeat (LRRC) family, which is known for its ability to form tight protein-protein interactions and to participate in various signaling pathways. LRRC41 is highly conserved across various species, and it has been implicated in various biological processes, including cell signaling, DNA replication, and stress response.

One of the unique features of LRRC41 is its ability to form a stable interaction with other proteins. LRRC41 contains a nucleotide-binding domain (NBD) that is known for its ability to form a covalent complex with specific nucleotides. This interaction between LRRC41 and nucleotides has been implicated in various cellular processes, including DNA replication, transcription, and gene expression.

In addition to its role in cellular signaling, LRRC41 has also been implicated in the regulation of various gene expression pathways. LRRC41 has been shown to play a role in the regulation of gene expression by binding to specific DNA sequences and by influencing the activity of RNA polymerase.

LRRC41 has also been shown to play a role in the regulation of DNA replication. LRRC41 has been shown to interact with the protein Hexon, which is involved in the regulation of DNA replication. This interaction between LRRC41 and Hexon has been shown to play a role in the regulation of DNA replication and has implications for the development of cancer.

In addition to its role in cellular signaling and DNA replication, LRRC41 has also been implicated in the regulation of stress response. LRRC41 has been shown to play a role in the regulation of stress response by binding to specific DNA sequences and by influencing the activity of signaling pathways that are involved in stress response.

LRRC41 has also been shown to play a role in the regulation of inflammation. LRRC41 has been shown to interact with the protein NF-kappa-B, which is involved in the regulation of inflammation. This interaction between LRRC41 and NF-kappa-B has been shown to play a role in the regulation of inflammation and has implications for the development of inflammatory diseases.

LRRC41 has also been implicated in the regulation of cell adhesion. LRRC41 has been shown to interact with the protein cadherin, which is involved in the regulation of cell adhesion. This interaction between LRRC41 and cadherin has been shown to play a role in the regulation of cell adhesion and has implications for the development of cancer.

In conclusion, LRRC41 (MUF1) protein is a highly conserved protein that has been implicated in various cellular processes. Its ability to form a stable interaction with other proteins and its role in the regulation of DNA replication, stress response, inflammation, and cell adhesion make it an attractive drug target and a potential biomarker for various diseases. Further research is needed to fully understand the role of LRRC41 in cellular processes and its potential as a drug target.

Protein Name: Leucine Rich Repeat Containing 41

Functions: Probable substrate recognition component of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins

The "LRRC41 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC41 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets